Source: Annual Congress 2002 - New trends in pulmonary imaging
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. E. Stanton, E. Millar, R. D. H. Monie, S. Kelly (Glasgow, United Kingdom). The role of ^99mTc labelled depreotide scanning in investigating suspected lung cancer - more than just the solitary pulmonary nodule. Eur Respir J 2002; 20: Suppl. 38, 2897

Member's Comments

No comment yet.

Related content which might interest you: The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 Radionuclid 99mTc – depreotide in the diagnosis of solitary pulmonary nodules Source: Eur Respir J 2004; 24: Suppl. 48, 48s Year: 2004 Radionuclid 99mTc – depreotide in the diagnosis of solitary pulmonary nodules Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003 Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodule Source: Eur Respir J 2005; 26: Suppl. 49, 312s Year: 2005 Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 99mTc-tetrofosmin (TF) SPECT usefulness in solitary pulmonary nodules Source: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005 The usefulness of dynamic CT and 18F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule Source: Eur Respir J 2007; 30: Suppl. 51, 532s Year: 2007 18F-FDG (fluorodeoxyglucose) uptake in focal organizing pneumonia mimicking bronchial carcinoma Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 The role of 99m-Tc-Depreotide scintigraphy in discriminating between malignant and benign pulmonary nodules Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005 Pulmonary ANCA-associated vasculitis mimicking a lung tumour or diffuse lung metastases (with positive PET-CT scan) Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018 Scintigraphic imaging (SPECT) with 99mTc-depreotide to differentiate benign vs. malignant solitary pulmonary nodules (SPN): results from a multicentre study Source: Annual Congress 2004 - Recent advances in modern chest imaging and their implications on various clinical problems Year: 2004 Solitary pulmonary nodules on PET scans – follow up strategy and outcome of low uptake nodules Source: Eur Respir J 2005; 26: Suppl. 49, 313s Year: 2005 An 8 year- review of granulomatous inflammation in EBUS samples- common in sarcoidosis, rare but identified in the setting of cancer where FDG uptake can be observed on PET scanning. Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 The role of 18-FDG PET/CT in lung sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 CT-PET scanning in suspected lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 672s Year: 2004 A lung cancer patient with multiple lesions on PET scan Source: Annual Congress 2006 - Clinical Grand Round: an interactive session Year: 2006 Evaluation of solitary pulmonary nodules (SPN) with 99mTc-MIBI lung scans in an area with high prevalence of tuberculosis: A pilot study Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003 Scintigraphy with 99mTc-depreotide has a high sensitivity in detecting lung cancer Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 Role of Tc-99m MIBI chest SPECT to detect mediastinal lymph node metastasis in patients with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 314s Year: 2005 Endobronchial ultrasound and PET mediastinal hot spots in lung cancer patients Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007